REQUEST A DEMO
Total
USD $0.00
Search more companies

Convatec (Singapore) Pte. Ltd. (Singapore)

Main Activities: Drugs and Druggists' Sundries Merchant Wholesalers
Secondary Activities: Pharmacies and Drug Stores
Full name: Convatec (Singapore) Pte. Ltd. Profile Updated: March 29, 2024
Buy our report for this company USD 29.95 Most recent financial data: 2022 Available in: English Download a sample report

Primary Business Activity: wholesale of medicinal and pharmaceutical products (western); Secondary Business Activity: pharmacies and drug stores (western)

Headquarters
456 Alexandra Road, #18-02 Fragrance Empire Building, Singapore
Singapore; Singapore; Postal Code: 119962

Contact Details: Purchase the Convatec (Singapore) Pte. Ltd. report to view the information.

Basic Information
Total Employees:
Purchase the Convatec (Singapore) Pte. Ltd. report to view the information.
Outstanding Shares:
Purchase the Convatec (Singapore) Pte. Ltd. report to view the information.
Financial Auditors:
Purchase the Convatec (Singapore) Pte. Ltd. report to view the information.
Incorporation Date:
May 26, 2008
Key Executives
Purchase this report to view the information.
Director
Purchase this report to view the information.
Director
Purchase this report to view the information.
Company Secretary
Ownership Details
Purchase this report to view the information.
100%
Company Performance
Financial values in the chart are available after Convatec (Singapore) Pte. Ltd. report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency SGD. Absolute financial data is included in the purchased report.
Net sales revenue
13.9%
Total operating revenue
13.9%
Net Profit (Loss) for the Period
-26.57%
Total assets
-26.04%
Total equity
-15.34%
Net Profit Margin
-8.01%
Return on Equity (ROE)
-37.07%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?